DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Sai Parenterals Limited — Acquisition (including agreement to acquire)-XBRL

NSE 1 hr ago·12 Aug 2026, 10:34 am

SAIPARENT NSE

Sai Parenterals Limited has announced a significant corporate development by informing the stock exchange about an acquisition. This move involves entering into an agreement to acquire a business or asset, marking a strategic expansion for the company.

For investors, this news signals a potential shift in the company's growth trajectory. Such acquisitions can indicate a management team's intent to diversify revenue streams or enter new markets, which may influence the stock's future performance.

Investors should monitor the exchange filing for further details, including the target company's identity and the financial terms of the deal. Keeping an eye on how the market reacts to this news will be key to understanding its impact on SAIPARENT.